{"article_title": "Rising Fees Pinch Some Pharmacies", "article_keywords": ["sharp", "received", "pinch", "sold", "rise", "sale", "rising", "deninger", "fees", "pharmacies", "type", "usmichael", "profits"], "article_url": "http://www.wsj.com/articles/rising-fees-pinch-some-pharmacies-1446024600", "article_text": "A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.\n\nMichael Deninger, owner of three pharmacies in Iowa, initially pocketed a profit of $9.49 after he sold a 5-milliliter bottle of Bausch & Lomb\u2019s prescription eye drop Lotemax\u2014which came at an initial cost $145.53. At the time of sale, Mr. Deninger said he received $7.75 from the patient in the form of a copay,...", "article_metadata": {"article.template": "snippet", "article.created": "2015-10-28T09:30:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.", "creator": "@pziobro", "image": {"src": "https://si.wsj.net/public/resources/images/BN-KY983_PHARMA_G_20151027204737.jpg", "alt": "Rising fees associated with a popular type of drug plan are eroding pharmacies\u2019 profits", "identifier": "https://si.wsj.net/public/resources/images/BN-KY983_PHARMA_D_20151027204737.jpg"}, "title": "Rising Fees Pinch Some Pharmacies", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10200446557404923797204581269390669102946&headline=Rising%20fees%20associated%20with%20a%20popular%20type%20of%20drug%20plan%20are%20eroding%20pharmacies%u2019%20profits&weburl=http://www.wsj.com/articles/SB10200446557404923797204581269390669102946"}}, "page.site.product": "WSJ", "keywords": "dir,medicare part d,pharmacies,preferred networks,profits,retroactive fee,Bausch & Lomb,financial performance,earnings,corporate,industrial news,pharmaceuticals,medical equipment,supplies,retail,wholesale,drug stores,specialty stores,insurance,health care,life sciences,eyewear,financial services,healthcare support services,pharmacy benefit management,medical,surgical instruments,apparatus,devices,prescription drugs,eyeglasses,spectacles,therapeutic devices,equipment", "news_keywords": "dir,medicare part d,pharmacies,preferred networks,profits,retroactive fee,Bausch & Lomb,financial performance,earnings,corporate", "article.headline": "Rising fees associated with a popular type of drug plan are eroding pharmacies\u2019 profits", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-KY983_PHARMA_E_20151027204737.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-KY983_PHARMA_D_20151027204737.jpg"}}, "description": "A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10200446557404923797204581269390669102946&headline=Rising%20fees%20associated%20with%20a%20popular%20type%20of%20drug%20plan%20are%20eroding%20pharmacies%u2019%20profits&weburl=http://www.wsj.com/articles/SB10200446557404923797204581269390669102946", "user.type": "nonsubscriber", "article.page": "Business", "page.content.format": "responsive", "article.summary": "A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.", "page.site": "wsj", "testkeys": "C", "article.published": "2015-10-28T17:57:00.000Z", "dj.asn": "i-c644", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 1, "image_count": 2, "word_count": 771, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.", "title": "Rising Fees Pinch Some Pharmacies", "url": "http://www.wsj.com/articles/rising-fees-pinch-some-pharmacies-1446024600", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-KY983_PHARMA_G_20151027204737.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Paul Ziobro", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Rising Fees Pinch Some Pharmacies", "article.type": "Business", "article.id": "SB10200446557404923797204581269390669102946", "user.exp": "default", "article.updated": "2015-10-28T17:57:00.000Z"}, "article_summary": "At the time of sale, Mr. Deninger said he received $7.75 from the patient in the form of a copay,...\nA sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies\u2019 profits across the U.S.Michael Deninger, owner of three pharmacies in Iowa, initially pocketed a profit of $9.49 after he sold a 5-milliliter bottle of Bausch & Lomb\u2019s prescription eye drop Lotemax\u2014which came at an initial cost $145.53."}